A 27-year-old woman with a past medical history of hypothyroidism presented to the clinic for concerns of a lesion on her right knee at the site of a previous scar.
A 27-year-old woman with a past medical history of hypothyroidism presented to the clinic for concerns of a lesion on her right knee at the site of a previous scar.
A healthy 55-year-old woman with no prior skin cancer history and no personal or family history of genodermatoses presented with a painless lesion on the right central cheek.
A healthy 55-year-old woman with no prior skin cancer history and no personal or family history of genodermatoses presented with a painless lesion on the right central cheek.
A healthy 42-year-old woman with fair skin (Fitzpatrick type 2) and no significant past medical history presented to the clinic with concerns about a dry, rough lesion on her left ear.
A healthy 42-year-old woman with fair skin (Fitzpatrick type 2) and no significant past medical history presented to the clinic with concerns about a dry, rough lesion on her left ear.
Ömer Kutlu, MD, MRCP, EBDV, and Özlem Acar Dirican, MD
A 71-year-old man with a history of a prostate adenocarcinoma and chronic lymphocytic leukemia for which he has been properly treated and monitored by the oncology department presented to our clinic with a single pink growth on the palm of...
A 71-year-old man with a history of a prostate adenocarcinoma and chronic lymphocytic leukemia for which he has been properly treated and monitored by the oncology department presented to our clinic with a single pink growth on the palm of...
In this podcast, The Dermatologist met with Dr Vernon Sondak to discuss his recent session, “Update on the Latest Advances in Treatment of Melanoma,” at the 2023 AAD Annual Meeting.
In this podcast, The Dermatologist met with Dr Vernon Sondak to discuss his recent session, “Update on the Latest Advances in Treatment of Melanoma,” at the 2023 AAD Annual Meeting.
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...